Literature DB >> 32625307

ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals.

.   

Abstract

ECDC, EFSA and EMA have jointly established a list of harmonised outcome indicators to assist EU Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance (AMR) in both humans and food-producing animals. The proposed indicators have been selected on the basis of data collected by Member States at the time of publication. For humans, the proposed indicators for antimicrobial consumption are: total consumption of antimicrobials (limited to antibacterials for systemic use), ratio of community consumption of certain classes of broad-spectrum to narrow-spectrum antimicrobials and consumption of selected broad-spectrum antimicrobials used in healthcare settings. The proposed indicators for AMR in humans are: meticillin-resistant Staphylococcus aureus and 3rd-generation cephalosporin-resistant Escherichia coli, Klebsiella pneumoniae resistant to aminoglycosides, fluoroquinolones and 3rd-generation cephalosporins, Streptococcus pneumoniae resistant to penicillin and S. pneumoniae resistant to macrolides, and K. pneumoniae resistant to carbapenems. For food-producing animals, indicators for antimicrobial consumption include: overall sales of veterinary antimicrobials, sales of 3rd- and 4th-generation cephalosporins, sales of quinolones and sales of polymyxins. Finally, proposed indicators for AMR in food-producing animals are: full susceptibility to a predefined panel of antimicrobials in E. coli, proportion of samples containing ESBL-/AmpC-producing E. coli, resistance to three or more antimicrobial classes in E. coli and resistance to ciprofloxacin in E. coli. For all sectors, the chosen indicators, which should be reconsidered at least every 5 years, are expected to be valid tools in monitoring antimicrobial consumption and AMR. With the exception of the proposed human AMR indicators, the indicators are in general not suitable to monitor the effects of targeted interventions in a specific sector, such as in a single animal species or animal production sector. Management decisions should never be based on these indicators alone but should take into account the underlying data and their analysis.
© 2017 European Centre for Disease Prevention and Control, © European Food Safety Authority and © European Medicines Agency. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Entities:  

Keywords:  antimicrobial consumption; antimicrobial resistance; food‐producing animals; humans; indicator

Year:  2017        PMID: 32625307      PMCID: PMC7009961          DOI: 10.2903/j.efsa.2017.5017

Source DB:  PubMed          Journal:  EFSA J        ISSN: 1831-4732


  16 in total

1.  Changes in US Outpatient Antibiotic Prescriptions From 2011-2016.

Authors:  Laura M King; Monina Bartoces; Katherine E Fleming-Dutra; Rebecca M Roberts; Lauri A Hicks
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

2.  Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection.

Authors:  Marc Pfister; Jennifer Keiser; Janneke M Brussee; Noemi Hiroshige; Anna Neodo; Jean T Coulibaly
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

3.  Prevalence of Vancomycin-Resistant Enterococcus (VRE) in Companion Animals: The First Meta-Analysis and Systematic Review.

Authors:  Yusuf Wada; Ahmad Adebayo Irekeola; Engku Nur Syafirah E A R; Wardah Yusof; Lee Lih Huey; Suwaiba Ladan Muhammad; Azian Harun; Chan Yean Yean; Abdul Rahman Zaidah
Journal:  Antibiotics (Basel)       Date:  2021-01-31

4.  Antimicrobial resistance clusters in commensal Escherichia coli from livestock.

Authors:  Ayla Hesp; Cajo Ter Braak; Jeanet van der Goot; Kees Veldman; Gerdien van Schaik; Dik Mevius
Journal:  Zoonoses Public Health       Date:  2021-01-17       Impact factor: 2.702

Review 5.  White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.

Authors:  Monica Compri; Rodolphe Mader; Elena Mazzolini; Giulia de Angelis; Nico T Mutters; Nithya Babu Rajendran; Liliana Galia; Evelina Tacconelli; Remco Schrijver
Journal:  J Antimicrob Chemother       Date:  2020-12-06       Impact factor: 5.790

6.  The impacts of New Zealand's COVID-19 epidemic response on community antibiotic use and hospitalisation for pneumonia, peritonsillar abscess and rheumatic fever.

Authors:  Eamon Duffy; Mark Thomas; Thomas Hills; Stephen Ritchie
Journal:  Lancet Reg Health West Pac       Date:  2021-06-09

Review 7.  Nanomaterials and Essential Oils as Candidates for Developing Novel Treatment Options for Bovine Mastitis.

Authors:  Andra Sabina Neculai-Valeanu; Adina Mirela Ariton; Bianca Maria Mădescu; Cristina Mihaela Rîmbu; Şteofil Creangă
Journal:  Animals (Basel)       Date:  2021-05-31       Impact factor: 2.752

8.  Role played by the environment in the emergence and spread of antimicrobial resistance (AMR) through the food chain.

Authors:  Konstantinos Koutsoumanis; Ana Allende; Avelino Álvarez-Ordóñez; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Lieve Herman; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Héctor Argüello; Thomas Berendonk; Lina Maria Cavaco; William Gaze; Heike Schmitt; Ed Topp; Beatriz Guerra; Ernesto Liébana; Pietro Stella; Luisa Peixe
Journal:  EFSA J       Date:  2021-06-17

9.  Progress towards antibiotic use targets in eight high-income countries.

Authors:  Bryony Simmons; Koya Ariyoshi; Norio Ohmagari; Celine Pulcini; Benedikt Huttner; Sumanth Gandra; Giovanni Satta; Lorenzo Moja; Michael Sharland; Nicola Magrini; Marisa Miraldo; Graham Cooke
Journal:  Bull World Health Organ       Date:  2021-04-29       Impact factor: 9.408

10.  Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018.

Authors:  Katrin Claire Leitmeyer; Laura Espinosa; Eeva Kaarina Broberg; Marc Jean Struelens
Journal:  Euro Surveill       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.